Literature DB >> 9059474

Nasal responsiveness to allergen and histamine in patients with perennial rhinitis with and without a late phase response.

C de Graaf-in't Veld1, I M Garrelds, A W van Toorenenbergen, R Gerth van Wijk.   

Abstract

BACKGROUND: In the lower airways an association has been found between early phase reaction (EPR), late phase reaction (LPR), and bronchial hyperreactivity. However, this association has not been shown for the upper airways in nasal pollen challenge studies. A study was undertaken to determine whether the EPR, LPR, and nasal hyperreactivity are related in perennial allergic rhinitis.
METHODS: Twenty four patients with rhinitis who were allergic to house dust mite (HDM) were challenged with HDM extract. The nasal response was monitored by symptom scores and nasal lavages for up to 9.5 hours after challenge and concentrations of albumin, tryptase, and eosinophil cationic protein (ECP) in the lavage fluid were measured. Thirteen patients (defined as dual responders) had increased symptom scores between 3.5 and 9.5 hours compared with the baseline score. The other 11 patients (defined as early responders) showed an isolated EPR only. Nasal hyperreactivity was determined by nasal histamine challenge 24 hours later.
RESULTS: Dual responders showed a significantly higher symptom score, albumin influx, and tryptase release during the EPR. During the late phase (3.5-9.5 hours) albumin influx was significantly increased at most time points and ECP release was significantly higher at 9.5 hours in the dual responder group. Dual responders showed a significantly stronger response to all doses of histamine. The area under the curve (AUC) of symptom scores during EPR and LPR and the AUC of the histamine dose response were significantly correlated (EPR-LPR: r = 0.49, p < 0.01; EPR-histamine: r = 0.75, p < 0.001; LPR-histamine: r = 0.66, p < 0.001).
CONCLUSIONS: In patients with perennial allergic rhinitis the nasal responses to allergen and histamine are associated. Dual responders have an increased EPR, increased levels of mediators, and increased allergen-induced hyperreactivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059474      PMCID: PMC1758482          DOI: 10.1136/thx.52.2.143

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.

Authors:  C Svensson; C R Baumgarten; U Pipkorn; U Alkner; C G Persson
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

2.  Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells.

Authors:  L B Schwartz
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

3.  Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.

Authors:  B Lebel; J Bousquet; A Morel; I Chanal; P Godard; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1988-11       Impact factor: 10.793

4.  Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses.

Authors:  S R Durham; C F Craddock; W O Cookson; M K Benson
Journal:  J Allergy Clin Immunol       Date:  1988-11       Impact factor: 10.793

5.  The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

Authors:  R Bascom; U Pipkorn; L M Lichtenstein; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-08

6.  Mediator release after nasal airway challenge with allergen.

Authors:  R M Naclerio; H L Meier; A Kagey-Sobotka; N F Adkinson; D A Meyers; P S Norman; L M Lichtenstein
Journal:  Am Rev Respir Dis       Date:  1983-10

7.  Inflammatory mediators in late antigen-induced rhinitis.

Authors:  R M Naclerio; D Proud; A G Togias; N F Adkinson; D A Meyers; A Kagey-Sobotka; M Plaut; P S Norman; L M Lichtenstein
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

8.  Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.

Authors:  C R Baumgarten; A G Togias; R M Naclerio; L M Lichtenstein; P S Norman; D Proud
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Histamine and methacholine do not increase nasal reactivity.

Authors:  H Grønborg; P Borum; N Mygind
Journal:  Clin Allergy       Date:  1986-11

10.  Allergen-induced specific and non-specific nasal reactions. Reciprocal relationship and inhibition by topical glucocorticosteroids.

Authors:  M Andersson; P Andersson; U Pipkorn
Journal:  Acta Otolaryngol       Date:  1989 Mar-Apr       Impact factor: 1.494

View more
  3 in total

1.  Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B.

Authors:  Rong Sun; Xinye Tang; Hongbing Yao; Suling Hong; Yang Yang; Wei Kou; Ping Wei
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

2.  PDE3 Inhibition Reduces Epithelial Mast Cell Numbers in Allergic Airway Inflammation and Attenuates Degranulation of Basophils and Mast Cells.

Authors:  Jan Beute; Keerthana Ganesh; Hedwika Nastiti; Robin Hoogenboom; Vivica Bos; Jelle Folkerts; Marco W J Schreurs; Steve Hockman; Rudi W Hendriks; Alex KleinJan
Journal:  Front Pharmacol       Date:  2020-05-01       Impact factor: 5.810

3.  The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy.

Authors:  Johanna Petronella Margaretha van der Valk; Birgit Nagl; Roy Gerth van Wljk; Barbara Bohle; Nicolette Wilma de Jong
Journal:  Nutrients       Date:  2020-02-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.